Email Us Here

Aquila Solutions, LLC Partners with Evofem, Inc. to Submit New Drug Application to U.S. FDA for Amphora as a Contraceptive

After partnering with Aquila's eCTD publishing support, Evofem, Inc. announced that they have submitted a large New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of Amphora as a contraceptive vaginal gel for women